Filana Therapeutics, Inc.
FLNA· Nasdaq
FLNAFilana Therapeutics, Inc.
Filed Oct 29, 2019 · 10-Q · 29 days after period end · 0001069530-19-000036
| Metric | Q3 2019 | Q3 2018 | Q3 2017 | Q3 2016 |
|---|---|---|---|---|
| Net Income | -$697.00K | -$1.27M | -$2.59M | -$3.52M |
| EPS Diluted | -$0.04 | -$0.11 | -$0.40 | -$0.54 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Filana Therapeutics, Inc. · CIK 1069530 · Engraved from SEC EDGAR
ended Sep 30, 2019 · filed Oct 29, 2019 · 29 d after period end
